Beta Bionics BBNX
NASDAQ BBNX
$17.81 +1.29 (+7.81%)
At close: Nov 11, 2026 · 4:00 PM EST

Beta Bionics (BBNX) Preferred Stock Liabilities (2023 - 2025)

Updated

Beta Bionics (BBNX) recorded Preferred Stock Liabilities of $321.37 million in Q4 2024, up 22.8% from $261.71 million a year earlier and up 22.8% from the prior quarter.

Analysis

Beta Bionics (BBNX) Preferred Stock Liabilities (2023 - 2025) Analysis & Trends

Starting with Q4 2023, Beta Bionics' Preferred Stock Liabilities history includes 5 quarters.

  • Across earlier years, Preferred Stock Liabilities came in at $261.71 million in FY2023.
  • Per Business Quant, the preceding three quarters came in at $261.71 million (Q3 2024), $261.71 million (Q2 2024) and $261.71 million (Q1 2024).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Thermo Fisher Scientific 266.22 Bn 242.86 Bn 5.13 Bn -
2 Abbott Laboratories 191.31 Bn 165.77 Bn 7.39 Bn -
3 Danaher 166.16 Bn 145.82 Bn 3.84 Bn -
4 Intuitive Surgical 155.98 Bn 136.40 Bn 2.08 Bn -
5 Medtronic 130.05 Bn 96.18 Bn 6.34 Bn -
6 Stryker 123.40 Bn 109.59 Bn 4.25 Bn -
7 Boston Scientific 64.81 Bn 60.48 Bn 3.43 Bn -
8 Edwards Lifesciences 59.87 Bn 43.18 Bn 1.35 Bn -
9 Medline 53.84 Bn 50.96 Bn 1.93 Bn -
10 Beta Bionics 898.08 Mn 58.74 Mn 20.33 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 321.37 Mn
Sep 30, 2025 5.13 Bn
Jun 30, 2025 321.37 Mn
Mar 31, 2025 321.37 Mn
Dec 31, 2024 321.37 Mn
Sep 30, 2024 261.71 Mn
Jun 30, 2024 261.71 Mn
Mar 31, 2024 261.71 Mn
Dec 31, 2023 261.71 Mn
API Access

Beta Bionics Preferred Stock Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=BBNX&period=max&api_key=YOUR_API_KEY